COVID-19 vaccines in elderly subjects: Considerations on efficacy and safety
<p>The SARS-CoV-2 pandemic dramatically involved elderly subjects, causing a very high number of deaths in this specific population, with a risk of mortality reaching 50% in subjects older than 80 years [1-3]. As a consequence, as the world prepares for a mass campaign to vaccinate as many peo...
Saved in:
Main Author: | Marco Bongiovanni (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2021-05-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The future of elder care in Italy in COVID-19 pandemic times: Socio-economic considerations
by: Chiara Bugariand Giovanni Lamura
Published: (2020) -
Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine
by: Reynaldo Oliva-Hernández
Published: (2021) -
Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation
Published: (2023) -
COVID-19 Vaccines Current State and Perspectives
Published: (2023) -
Clinical Features of COVID-19 in Elderly Patients
Published: (2023)